Home
NOTÍCIAS
Caro Participante,
Sua opinião é muito importante para nós. Por favor, responda o questionário on-line a respeito de sua experiência na 8ª Conferência Anual HTAi.
Acesse: http://www.surveymonkey.com
Equipe Organizadora do HTAi 2011



       
imprimir esta página enviar este link por e-mail
SESSÕES ORAIS
APRESENTAÇÕES EM PDF


• OS16 - Medicines Policy and Sustainability;

236 - Exceptional Higher Allowed Price of Medicines in Slovenia. Does HTA Fit In?
Eva Turk
   E.T. PDF version

379 - Multiple Demand Side Measures Needed to Enhance Prescribing of Generics for Sustainable Healthcare: Experiences From Abu Dhabi
Brian Godman		   
   B.G. PDF version

448 - Policy Framework for Tiered Pricing to Improve Access and Affordability of Medicines In Low and Middle Income Countries
Rutger Daems		   
   R.D. PDF version

660 - Management Model to Replace an Original High Cost Drug for a Generic Formulation. Evaluation, Monitoring and Results
Abayubá Perna		   
   A.P.F. PDF version

816 - The Effect of HTA on Reimbursed Pharmaceutical Prices – Preliminary Results from an International Empirical Analysis
Peter Davey		   
   P.D. PDF version

• OS17 - Applying of Health Technology Assessment;

594 - Evidence Based Essential Medicines and Herbal Medicines Selection: Training of Brazilian Expert Commissions
Marcus Tolentino Silva
   M.T.S. PDF version

706 – The Role of DECIT on Decision Making About Incorporation Of Health Technologies In Brazilian Health System In 2010
Flávia Cristina Ribeiro Salomon
   F.C.R.S. PDF version
 
• OS18 - HTA Report Utilization;

304 - Evaluation of Implementation Process of Prenatal Screening in Finland
Ulla Saalasti-Koskinen		   
   U.S.K. PDF version

460 - Telemedicine Support on Maternal and Newborn Health in Remote Provinces of Mongolia
Oyun Chimeddamba		   
   O.C. PDF version

518 - Review of Decision-Analytic Models in Chronic Myeloid Leukemia
Ursula Rochau		   
   U.R. PDF version

736 - Review of Studies on Economic Evaluation of Treatment for Osteoporosis Postmenopausal
Cristina Mariano Ruas Brandão		   
   C.M.R.B. PDF version

• OS19 - National Health Policies And HTA Agencies;

214 - North-South and South-South HTA Transferability: The Experiences of Latin American Researchers and Decision-Makers in Using HTA Reports from Other Jurisdictions
Andres Pichon-Riviere
   A.P. PDF version

393 - Innovative Health Technologies: Criteria and Incentives in France
Sun-Hae Lee-Robin		   
   S.H.L.R. PDF version

462 - Accountability for Reasonableness of Drug Reimbursement Systems: Comparison of the Austrian, Belgian, Dutch, French and Swedish System and Development of a Transparency Framework for Decision Making
Irina Cleemput		   
   I.C. PDF version

899 - HTA: The Anchor in a Sea Of Political Change
Peter Littlejohns		   
   P.L. PDF version

945 - Institutionalizing HTA in Brazil: A Comparative Analysis With the UK, Canada and Australia
Vania Cristina Canuto Santos		   
   V.C.C.S. PDF version

• OS20 - HTA and Patient Perspective;

374 - Strategies to Enroll Patients to an Integrated Program for Breast Cancer Care – A Partnership Between Health Services, Schools and a Non-Governmental Organization
Camila Cristina Pires Nascimento 		  
   C.C.P.N. PDF version

430 - Introducing Patients’ Perspective in Health Technology Assessment at the Local Level: A Qualitative Study Among HTA Producers and Hospital Managers
Marie-Pierre Gagnon 		  
   M.P.G. PDF version

956 - Ethics and Policy in HTA: Patient Preferences at Odds With HTA- The Example of Autologous Blood Donation for Spinal Fusion
David A Wong 		  
   D.A.W PDF version


 

1-2-3-4-5-6